NASDAQ:GYRO

Gyrodyne Stock Forecast, Price & News

$13.54
+0.26 (+1.96 %)
(As of 06/14/2021 12:00 AM ET)
Add
Compare
Today's Range
$13.15
$14.00
50-Day Range
$11.50
$17.10
52-Week Range
$11.50
$17.75
Volume4,322 shs
Average Volume3,041 shs
Market Capitalization$20.03 million
P/E RatioN/A
Dividend YieldN/A
Beta0.42
30 days | 90 days | 365 days | Advanced Chart
Receive GYRO News and Ratings via Email

Sign-up to receive the latest news and ratings for Gyrodyne and its competitors with MarketBeat's FREE daily newsletter.


About Gyrodyne

Gyrodyne, LLC. owns, leases and manages diverse commercial properties. The firm is distinguished by its service-oriented philosophy toward property ownership and management. Gyrodyne has grown from a largely Long Island player during the past into a diversified East Coast presence with an emphasis on medical office product.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.79 out of 5 stars

Finance Sector

1329th out of 1,976 stocks

Nonresidential Building Operators Industry

7th out of 11 stocks

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Gyrodyne (NASDAQ:GYRO) Frequently Asked Questions

What stocks does MarketBeat like better than Gyrodyne?

Wall Street analysts have given Gyrodyne a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Gyrodyne wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Gyrodyne?

Gyrodyne saw a decline in short interest in the month of May. As of May 14th, there was short interest totaling 200 shares, a decline of 50.0% from the April 29th total of 400 shares. Based on an average trading volume of 2,200 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.0% of the company's shares are short sold.
View Gyrodyne's Short Interest
.

How has Gyrodyne's stock price been impacted by Coronavirus (COVID-19)?

Gyrodyne's stock was trading at $18.5084 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, GYRO stock has decreased by 26.9% and is now trading at $13.5366.
View which stocks have been most impacted by COVID-19
.

Who are Gyrodyne's key executives?

Gyrodyne's management team includes the following people:
  • Mr. Gary Jay Fitlin, Pres, CEO, CFO & Treasurer (Age 56, Pay $250k)
  • Mr. Peter Pitsiokos, Chief Compliance officer, COO, Exec. VP & Sec. (Age 61, Pay $200k)
  • Mr. Dawn Ibraham, Controller

Who are some of Gyrodyne's key competitors?

What other stocks do shareholders of Gyrodyne own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Gyrodyne investors own include Acasti Pharma (ACST), Amyris (AMRS), Ariad Pharmaceuticals (ARIA), Astrotech (ASTC), Athersys (ATHX), (AVNR) (AVNR), Bank of America (BAC), Citigroup (C), China Auto Logistics (CALI) and (CHTP) (CHTP).

What is Gyrodyne's stock symbol?

Gyrodyne trades on the NASDAQ under the ticker symbol "GYRO."

Who are Gyrodyne's major shareholders?

Gyrodyne's stock is owned by a number of institutional and retail investors. Top institutional shareholders include GABELLI & Co INVESTMENT ADVISERS INC. (6.26%) and Gabelli Funds LLC (4.06%).
View institutional ownership trends for Gyrodyne
.

Which institutional investors are buying Gyrodyne stock?

GYRO stock was bought by a variety of institutional investors in the last quarter, including Gabelli Funds LLC, and GABELLI & Co INVESTMENT ADVISERS INC..
View insider buying and selling activity for Gyrodyne
or or view top insider-buying stocks.

How do I buy shares of Gyrodyne?

Shares of GYRO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Gyrodyne's stock price today?

One share of GYRO stock can currently be purchased for approximately $13.54.

How much money does Gyrodyne make?

Gyrodyne has a market capitalization of $20.03 million.

How many employees does Gyrodyne have?

Gyrodyne employs 6 workers across the globe.

What is Gyrodyne's official website?

The official website for Gyrodyne is www.gyrodyne.com.

Where are Gyrodyne's headquarters?

Gyrodyne is headquartered at 1 FLOWERFIELD SUITE 24, ST. JAMES NY, 11780.

How can I contact Gyrodyne?

Gyrodyne's mailing address is 1 FLOWERFIELD SUITE 24, ST. JAMES NY, 11780. The real estate investment trust can be reached via phone at (631) 584-5400.


This page was last updated on 6/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.